Literature DB >> 26813311

Detection of Free and Protein-Bound ortho-Quinones by Near-Infrared Fluorescence.

Joseph R Mazzulli1, Lena F Burbulla1, Dimitri Krainc1, Harry Ischiropoulos2,3.   

Abstract

Aging and oxidative stress are two prominent pathological mechanisms for Parkinson's disease (PD) that are strongly associated with the degeneration of dopamine (DA) neurons in the midbrain. DA and other catechols readily oxidize into highly reactive o-quinone species that are precursors of neuromelanin (NM) pigment and under pathological conditions can modify and damage macromolecules. The role of DA oxidation in PD pathogenesis remains unclear in part due to the lack of appropriate disease models and the absence of a simple method for the quantification of DA-derived oxidants. Here, we describe a rapid, simple, and reproducible method for the quantification of o-quinones in cells and tissues that relies on the near-infrared fluorescent properties of these species. Importantly, we demonstrate that catechol-derived oxidants can be quantified in human neuroblastoma cells and midbrain dopamine neurons derived from induced pluripotent stem cells, providing a novel model to study the downstream actions of o-quinones. This method should facilitate further study of oxidative stress and DA oxidation in PD and related diseases that affect the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26813311      PMCID: PMC5555314          DOI: 10.1021/acs.analchem.5b04420

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  32 in total

Review 1.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

2.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

3.  Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats.

Authors:  M J Zigmond; E M Stricker
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

4.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

6.  Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.

Authors:  Joseph R Mazzulli; Amanda J Mishizen; Benoit I Giasson; David R Lynch; Steven A Thomas; Akira Nakashima; Toshiharu Nagatsu; Akira Ota; Harry Ischiropoulos
Journal:  J Neurosci       Date:  2006-09-27       Impact factor: 6.167

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

8.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

9.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Authors:  Q Y Zhou; C J Quaife; R D Palmiter
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

10.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more
  13 in total

1.  3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.

Authors:  Yunden Jinsmaa; Yehonatan Sharabi; Patti Sullivan; Risa Isonaka; David S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2018-04-26       Impact factor: 4.030

Review 2.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

3.  N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Authors:  David S Goldstein; Yunden Jinsmaa; Patti Sullivan; Yehonatan Sharabi
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

Review 4.  Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Authors:  Yvette C Wong; Kelvin Luk; Kerry Purtell; Samuel Burke Nanni; A Jon Stoessl; Louis-Eric Trudeau; Zhenyu Yue; Dimitri Krainc; Wolfgang Oertel; Jose A Obeso; Laura A Volpicelli-Daley
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

5.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

Review 6.  Natural product-based amyloid inhibitors.

Authors:  Paul Velander; Ling Wu; Frances Henderson; Shijun Zhang; David R Bevan; Bin Xu
Journal:  Biochem Pharmacol       Date:  2017-04-06       Impact factor: 5.858

7.  Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.

Authors:  Lena F Burbulla; Pingping Song; Joseph R Mazzulli; Enrico Zampese; Yvette C Wong; Sohee Jeon; David P Santos; Judith Blanz; Carolin D Obermaier; Chelsee Strojny; Jeffrey N Savas; Evangelos Kiskinis; Xiaoxi Zhuang; Rejko Krüger; D James Surmeier; Dimitri Krainc
Journal:  Science       Date:  2017-09-07       Impact factor: 47.728

8.  Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.

Authors:  Danielle E Mor; Elpida Tsika; Joseph R Mazzulli; Neal S Gould; Hanna Kim; Malcolm J Daniels; Shachee Doshi; Preetika Gupta; Jennifer L Grossman; Victor X Tan; Robert G Kalb; Kim A Caldwell; Guy A Caldwell; John H Wolfe; Harry Ischiropoulos
Journal:  Nat Neurosci       Date:  2017-09-18       Impact factor: 24.884

9.  Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity.

Authors:  Malcolm J Daniels; J Brucker Nourse; Hanna Kim; Valerio Sainati; Marco Schiavina; Maria Grazia Murrali; Buyan Pan; John J Ferrie; Conor M Haney; Rani Moons; Neal S Gould; Antonino Natalello; Rita Grandori; Frank Sobott; E James Petersson; Elizabeth Rhoades; Roberta Pierattelli; Isabella Felli; Vladimir N Uversky; Kim A Caldwell; Guy A Caldwell; Edward S Krol; Harry Ischiropoulos
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

10.  Sensitive determination of dopamine levels via surface-enhanced Raman scattering of Ag nanoparticle dimers.

Authors:  Xiantong Yu; XiaoXiao He; Taiqun Yang; Litao Zhao; Qichen Chen; Sanjun Zhang; Jinquan Chen; Jianhua Xu
Journal:  Int J Nanomedicine       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.